Saxagliptin, in combination with metformin, provides a durable, well-tolerated, and cost-effective treatment option for patients with type 2 diabetes mellitus, from a US payer perspective.
Klas Bergenheim, PhD
Advertisement
Articles by Klas Bergenheim, PhD
Advertisement
Latest Updated Articles
- US Cost-Effectiveness of Saxagliptin in Type 2 Diabetes Mellitus
Published: February 11th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
2
A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin
3
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
4
FDA Approves First Drug for Pediatrics With Irritable Bowel Syndrome With Constipation
5
